Skip to main content
Premium Trial:

Request an Annual Quote

Thermo, Fisher Shareholders Approve Merger; Regulatory OK Still Sought

NEW YORK (GenomeWeb News) – Thermo Electron and Fisher Scientific International today said that their shareholders have approved their merger.
 
The companies said that the deal, the largest ever in the biotech industry, remains subject to regulatory approval.
 
As GenomeWeb News reported this week, Fisher said it would divest an undisclosed product line to satisfy the Federal Trade Commission.  The line is worth $17 million, Fisher said.
 
As originally expected, the $10.6 billion deal is scheduled to close by the end of the fourth quarter. The firms announced the deal in May.
The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.